Gilead Sciences (GILD) Tops Q3 EPS by 32c; offers guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $151.00 -0.15%
EPS Growth %: -14.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
PMCB, CULP, HURC, More
EPS Growth %: -14.2%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.47, $0.32 better than the analyst estimate of $2.15. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.45 billion.
GUIDANCE:
Gilead Sciences sees FY2025 EPS of $8.05-$8.25, versus the consensus of $8.05. Gilead Sciences sees FY2025 Product revenue of $28.4-28.7 billion, versus the consensus of $28.836 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
- UBS Upgrades Arbonia AG (ARBN:SW) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
